Corticosteroids in COVID-19: Optimizing Observational Research through Target Trial Emulations

Katherine L. Hoffman, Edward J. Schenck, Michael Satlin, William Whalen, Di Pan, Nicholas Williams, Iván Díaz
doi: https://doi.org/10.1101/2022.05.27.22275037

Article Information

doi 
https://doi.org/10.1101/2022.05.27.22275037
History 
  • May 29, 2022.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Katherine L. Hoffman1,*,
  2. Edward J. Schenck2,
  3. Michael Satlin3,
  4. William Whalen2,
  5. Di Pan2,
  6. Nicholas Williams4 and
  7. Iván Díaz1
  1. 1Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine
  2. 2Division of Pulmonary and Critical Care, Department of Medicine, Weill Cornell Medicine
  3. 3Division of Infectious Disease, Department of Medicine, Weill Cornell Medicine
  4. 4Department of Epidemiology, Mailman School of Public Health, Columbia University
  1. ↵* Corresponding author; email: kah2797{at}med.cornell.edu
Back to top
Posted May 29, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Corticosteroids in COVID-19: Optimizing Observational Research through Target Trial Emulations
Katherine L. Hoffman, Edward J. Schenck, Michael Satlin, William Whalen, Di Pan, Nicholas Williams, Iván Díaz
medRxiv 2022.05.27.22275037; doi: https://doi.org/10.1101/2022.05.27.22275037
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area